false
Catalog
Self-Assessment: Novel Therapeutic Approaches for ...
Dr. Li Presentation
Dr. Li Presentation
Back to course
Pdf Summary
Dr. Yuebing Li from the Cleveland Clinic presents a comprehensive overview of Myasthenia Gravis (MG) management, covering aspects from epidemiology to telemedicine. Recent trends indicate MG's rising incidence, particularly among young females and people over 65, while the prevalence of ocular MG has increased, and thymoma cases decreased.<br /><br />Key symptoms include ptosis, diplopia, bulbar symptoms, limb weakness, and respiratory failure, with the MG-ADL score guiding symptom recognition. Nutrition advice stresses vitamin D supplementation and avoiding malnutrition. Fatigue management includes physical and perception-based approaches, emphasizing both aerobic exercise and cognitive behavioral therapy.<br /><br />Sleep disorders such as sleep apnea and insomnia, influenced by MG and its treatments, necessitate proper management as poor sleep adversely impacts MG symptoms. Depression and anxiety are prevalent, necessitating careful treatment with select antidepressants while avoiding specific contraindicated medications.<br /><br />Exercise benefits MG patients by improving functional status and quality of life. Aerobic activities are recommended, but caution is advised to avoid overexertion. Infection management highlights both the risks of traditional and novel immunotherapies, particularly the heightened susceptibility to infections like PJP and meningococcal diseases; thus, vaccination and prophylactic strategies are crucial.<br /><br />The document also discusses appropriate use of acetylcholinesterase inhibitors (AChE), particularly pyridostigmine, noting its effectiveness and need for cautious long-term use due to potential morphological changes in the neuromuscular junction. Telemedicine's role in MG management, including expert guidance on conducting virtual assessments, is acknowledged as beneficial for patient oversight.<br /><br />Overall, the emphasis is on a multi-faceted approach to managing MG, prioritizing symptom monitoring, preventive measures, and tailored treatments to improve patient outcomes.
Keywords
Myasthenia Gravis
MG management
epidemiology
telemedicine
symptoms
exercise
infection management
acetylcholinesterase inhibitors
patient outcomes
2621 Superior Drive NW
Rochester, MN
P
507.288.0100
F
507.288.1225
aanem@aanem.org
Terms of Use
Privacy Statement
© 2024 American Association of Neuromuscular & Electrodiagnostic Medicine
×
Please select your language
1
English